Posted by Michael Wonder on 22 Dec 2024
FDA approves first acellular tissue engineered vessel to treat vascular trauma in extremities
20 December 2024 - The US FDA approved Symvess, the first acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularisation is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
Symvess is a sterile, acellular tissue engineered vessel composed of human extracellular matrix proteins typically found in human blood vessels.
